Olaparib In Metastatic Breast Cancer

NCT03344965 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Invasive Breast Cancer
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
CHEK2 Gene Mutation
ATM Gene Mutation
PALB2 Gene Mutation
RAD51 Gene Mutation
BRIP1 Gene Mutation
NBN Gene Mutation

Interventions

DRUG: Olaparib

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]
[object Object]
[object Object]